Preview

Problems of Endocrinology

Advanced search

Modern biochemical methods for the diagnostics of pheochromocytoma

https://doi.org/10.14341/probl201258210-15

Abstract

The objective of the present work was to estimate the possibility of using the ELISA technique for the quantitative analysis of the metanephrine and normetanephrine levels in urine and to determine the cross-off points for the discrimination between their normal and pathological values for the purpose of diagnostics of pheochromocytoma. Methylated derivatives of adrenaline and noradrenaline were measured in 3,234 urine sample obtained from the patients presenting with elevated arterial pressure, resistance to therapy, and adrenal mass lesions who had visited the inpatient and outpatient departments of the Endocrinological Research Centre during the past 4 years. The measurement of total metanephrine and normetanephrine (free plus deconjugated fractions) was performed using commercial ELISA kits (IBL, Hambutg, Germany). The content of normetanephrine over 612 mcg in daily urine samples was shown to be the borderline between the normal values and those suggesting diagnosis of pheochromocytoma. The sensitivity of this assay was 97,5% (95% CI 91,1-99,6%), specificity 100% (95% CI 93,8-100%). For metanephrine, the level of more than 550 mcg/24 hours was the borderline between the normal values and those suggesting diagnosis of pheochromocytoma. The sensitivity of the method was 100% (95% CI 88-100%), specificity - 96% (95% CI 86-99,4%). The biochemical diagnosis of pheochromocytoma was confirmed by the reference pathomorphological method in 99% of the cases. The incidence of pheochromocytoma predicted by the biochemical analysis of the urine samples delivered to the laboratory during 4 years from the patients with the tentative diagnosis of this pathology (based on the elevated arterial pressure and the presence of adrenal mass lesions) was 4% on the average. It is concluded that the application of ELISA in a "manual" mode provides high sensitivity and specificity of quantitative determination of metanephrines in daily urine comparable to those achieved with the widely used but more expensive high performance liquid chromatography.

References

1. Дедов И.И., Бельцевич Д.Г., Кузнецов Н.С., Мельниченко Г.А. Феохромоцитома. М: ООО "Практическая медицина" 2005.

2. Калинин А.П., Казанцева И.А., Полякова Г.А. и др. Надпочечниковые и вне-надпочечниковые феохромоцитомы. Учебное пособие. М 1998.

3. De Jong W.H.A., Eisenhofer G., Post W.J. et al. Dietary Influences on Plasma and Urinary Metanephrines: Implications for Diagnosis of Catecholamine-Producing Tumors. JCEM 2009; 94: 2841-2849.

4. Wassell J., Reed P., Kane J., Weinkove C. Freedom from drug interference in new immunoassays for urinary catecholamines and metanephrines. Clin Chem 1999; 45: 12: 2216-2223.

5. Neary N.M., King K.S., Pacak K. Drugs and Pheochromocytoma - Don't Be Fooled by Every Elevated Metanephrine. N Engl J Med 2011; 364: 2268-2270.

6. Юшков П.В. Гистопатология эндокринной системы (атлас). М: Издательский дом Куприянов 2007.

7. Кузнецов Н.С., Бельцевич Д.Г., Гончаров Н.П., Кац Л.Е., Кация Г.В., Колесникова Г.С., Ильин А.В., Мельниченко Г.А. Повышение уровня метилированных производных катехоламинов - патогномоничный лабораторный признак феохромоцитомы. Пробл эндокринол 2007; 53: 1.

8. Pacak K., Eisenhofer G., Ahlman H., Bornstein S.R., Gimenez-Roqueplo A.-P., Grossman A.B., Kimura N., Mannelli M., McNicol A.M., Tischler A.S. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nature Clin Practice Endocrinol Metab 2007; 3: 92-102.

9. Sawka A.M., Jaeschke R., Singh R.J., Young W.E. A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines. J Clin Endocrinol Metabol 2003; 88: 2: 553-558.

10. Grouzmann E., Drouard-Troalen L., Baudin E., Plouin P. F., Muller B., Grand D., Buclin T. et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol 2010; 162: 951-960.

11. Юкина М.Ю. Феохромоцитома/параганглиома: клинико-генетические аспекты диагностики и лечения: Автореф. дис. ... канд. мед. наук. М 2011.

12. Eisenhofer G., Lenders J.W., Timmers H., Mannelli M. et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 2011; 57: 3: 411-420.

13. Eisenhofer G., Goldstein D.S., Sullivan P., Csako G., Brouwers F.M., Lai E.W., Adams K.T., Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 2005; 90: 4: 2068-2075.

14. van Duinen N., Steenvoorden D., Kema I.P., Jansen J.C., Vriends A.H., Bayley J.P., Smit J.W., Romijn J.A., Corssmit E.P. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab 2010; 95: 1: 209-214


Review

For citations:


Goncharov N.P., Katsiia G.V., Malysheva N.M. Modern biochemical methods for the diagnostics of pheochromocytoma. Problems of Endocrinology. 2012;58(2):10-15. https://doi.org/10.14341/probl201258210-15

Views: 503


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)